Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ontario: Can$114m for new hospital:

This article was originally published in Clinica

Executive Summary

A significant financial boost of Can$114m (US$100m) - Can$13m of which are one-time operating funds - has been provided by the state government of Ontario to complete the state-of-the-art Brampton Civic Hospital. The facility, which has been in development since 2004 and is expected to be one of Ontario's best hospitals, is due to open at the end of 2007. The hospital will have an emergency department to accommodate 90,000 annual visits, and there will be a doubling of ambulatory care capacity for the area from 242,000 visits per year in 2006 to 400,000 in 2011-12. Its bed capacity will increase incrementally - starting with 479 (including 62 for emergency care), increasing to 527 in 2009-10, 570 in 2010-11 and 608 in 2011-12. The state government had provided funds of Can$18.9m for the project in 2006.

You may also be interested in...



Oxford/AstraZeneca Vaccine Shows 70% Efficacy As Company Prepares Approval Filings

Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.

EBITDA Margin Of 33% Not Sustainable, Krka Underlines

Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.

Pandemic Spotlights Tensions Between Profit And Philanthropy

The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.

Topics

UsernamePublicRestriction

Register

OM005385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel